The full billed price for a double lung transplant for a patient under 65 increased 81% between 2020 and this year, to $2.3 million, the firm estimates.
The company put out a statement on Friday rejecting the allegations, but the Wall Street Journal article caused a 7.17% drop in the price of its stock.